Intra-Cellular Therapies: Depression Data Boosts Investment Prospects, Upgrade Buy (ITCI)

Woman Praying In A Dark Place



Intra-Cellular Therapies (NASDAQ:ITCI), a pioneering biotech firm, is dedicated to the creation and market introduction of novel small molecule therapies, which are primarily targeted at fulfilling unfulfilled healthcare needs. Their primary focus lies in neuropsychiatric and neurological conditions, by

Data by YCharts

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button